R. Fanizzi

发表

Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

F. Iannone, G. Lapadula, C. Scioscia, 2013, Scandinavian journal of rheumatology.

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients.

F. Iannone, G. Lapadula, A. Notarnicola, 2015, Joint, bone, spine : revue du rhumatisme.

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study

M. Chimenti, A. Doria, R. Ramonda, 2021, RMD Open.

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors

M. Barone, A. Di Leo, G. Lopalco, 2018, Journal of clinical medicine.